ArticleHuman vaccines & immunotherapeutics2022

Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines.

Md Jamal Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.